Pernix Therapeutics Holdings, Inc. (PTX) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

United States, 25 pages report, published by GlobalData

Keywords : Pernix Therapeutics Holdings, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Report ThumbnailOctober-2016
Summary

Pernix Therapeutics Holdings, Inc. (Pernix Therapeutics) is a pharmaceutical company that manufactures, markets generic pharmaceutical products for pediatric market. The company provides branded and generic pharma products. It provides products in allergy, upper respiratory, including nasal, chest congestion and cough, antibiotics and dermatology areas. Pernix Therapeutics provides patient assistance programs and promotes its products through sales and marketing organizations. The company serves drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies. Pernix Therapeutics is headquartered in Morristown, New Jersey, the US.

Pernix Therapeutics Holdings, Inc. Key Recent Developments

Sep 16, 2016: Marsha Stanton, Ph.D., RN, Pernix Therapeutics Executive Director of Medical and Government Affairs, Awarded Prestigious Pain Management Advocacy Award from the American Society for Pain Management Nursing
Aug 11, 2016: Pernix Therapeutics Reports Second Quarter 2016 Financial Results and Business Update
Jul 26, 2016: Pernix Therapeutics Announces Reorganization of Senior Management Team
Jul 07, 2016: Pernix Therapeutics Announces Restructuring of Sales Force and Operations
May 11, 2016: Pernix Therapeutics Announces CEO Transition

This comprehensive SWOT profile of Pernix Therapeutics Holdings, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pernix Therapeutics Holdings, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • List of Figures
  • Pernix Therapeutics Holdings, Inc., Performance Chart
  • Pernix Therapeutics Holdings, Inc., Ratio Charts
  • List of Tables
  • Pernix Therapeutics Holdings, Inc., Key Information
  • Pernix Therapeutics Holdings, Inc., Key Ratios
  • Pernix Therapeutics Holdings, Inc., Share Data
  • Pernix Therapeutics Holdings, Inc., Major Products and Services
  • Pernix Therapeutics Holdings, Inc., History
  • Pernix Therapeutics Holdings, Inc., Key Employees
  • Pernix Therapeutics Holdings, Inc., Key Employee Biographies
  • Pernix Therapeutics Holdings, Inc., Key Operational Heads
  • Pernix Therapeutics Holdings, Inc., Other Locations
  • Pernix Therapeutics Holdings, Inc., Subsidiaries
  • Pernix Therapeutics Holdings, Inc., Key Manufacturing facilities
  • Pernix Therapeutics Holdings, Inc., Key Competitors
  • Pernix Therapeutics Holdings, Inc., SWOT Analysis
  • Pernix Therapeutics Holdings, Inc., Ratios based on current share price
  • Pernix Therapeutics Holdings, Inc., Annual Ratios
  • Pernix Therapeutics Holdings, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • Table of Contents
  • Section 1 - About the Company
  • Pernix Therapeutics Holdings, Inc. - Key Information
  • Pernix Therapeutics Holdings, Inc. - Overview
  • Pernix Therapeutics Holdings, Inc. - Key Employees
  • Pernix Therapeutics Holdings, Inc. - Key Employee Biographies
  • Pernix Therapeutics Holdings, Inc. - Key Operational Heads
  • Pernix Therapeutics Holdings, Inc. - Major Products and Services
  • Pernix Therapeutics Holdings, Inc. - History
  • Pernix Therapeutics Holdings, Inc. - Company Statement
  • Pernix Therapeutics Holdings, Inc. - Locations And Subsidiaries
  • Pernix Therapeutics Holdings, Inc. - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Pernix Therapeutics Holdings, Inc. - Business Description
  • Pernix Therapeutics Holdings, Inc. - Corporate Strategy
  • Pernix Therapeutics Holdings, Inc. - SWOT Analysis
  • SWOT Analysis - Overview
  • Pernix Therapeutics Holdings, Inc. - Strengths
  • Pernix Therapeutics Holdings, Inc. - Weaknesses
  • Pernix Therapeutics Holdings, Inc. - Opportunities
  • Pernix Therapeutics Holdings, Inc. - Threats
  • Pernix Therapeutics Holdings, Inc. - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Pernix Therapeutics Holdings, Inc. - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company

Please select a license type

Share

Related Products

GlobalDataPernix Therapeutics Holdings, Inc. (PTX) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailPernix Therapeutics Holdings, Inc. (PTX) - Financial and Strategic SWOT Analysis Review, Company Report available for $300Product #: 45953
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved